Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development, and commercialization of molecular biomarkers. It offers devTOX quickPredict, a screening service that uses human embryonic or induced pluripotent stem cells to screen drug candidates, chemicals, consumer products, and cosmetics for their potential effect on the developing human embryo. The company also focuses on the diagnosis and treatment of neurological disorders.